Author

Alyssa Wallstrum

PDX Pharmaceuticals (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Gordon MillsiD· 1 shared Moataz M. Reda· 1 shared Noah A. Crumrine· 1 shared Pramod KumariD· 1 shared Ruijie WangiD· 1 shared Tongchatra Watcharawittayakul· 1 shared Wassana YantaseeiD· 1 shared Worapol NgamcherdtrakuliD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Gordon MillsORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

High-Density Wild-Type IL-2 Nanoparticles Preferentially Enhance CD8⁺ T-Cell Expansion and Reprogram the Tumor Microenvironment

Ruijie Wang, Pramod Kumar, Noah A. Crumrine, Tongchatra Watcharawittayakul, Alyssa Wallstrum, Moataz M. Reda, Gordon Mills, Worapol Ngamcherdtrakul, Wassana Yantasee

This paper develops IL2-NP nanoparticles that enhance CD8 T-cell expansion and reprogram the tumor microenvironment, showing efficacy in multiple cancer models.

bioRxiv · Jul 15, 2026 · PreprintBioengineering